Issue link: https://www.e-digitaleditions.com/i/1056686
Information from companies that provide products and services that may be useful in research and development or manufacturing. Content is provided by companies, with no preference intended. Extra Focus This section of Inhalation provides information that may be useful in research and development or manufacturing. Content is provided by the companies listed. No product endorsement or preference is intended. ProDuct DEVELoPMENt Digital health services packages Connected devices can provide improved health out- comes through better patient education and dose adherence, especially with easy-to-use, intuitive devices. Aptar Pharma's new Digital Health Services packages bring added value for patients, their doctors and payers. These services include connected device platforms across our drug delivery systems to deliver fully inte- grated connected delivery systems into patients' hands. Aptar Pharma France: +33 139 17 20 20 www.aptar.com/pharma Inhalation December 2018 27 Development from pre-formulation to commercialization From its Center of Excellence in Research Triangle Park, North Carolina, US, Catalent Inhalation has the capa- bilities, experience and expertise to assist development from pre-formulation to commercialization, across a full range of inhaled dose forms: metered-dose inhalers (MDIs), dry powder inhalers (DPIs), nasal sprays (solu- tions/suspensions), nebulizers and liquid inhalers. Catalent also provides integrated analytical, particle size engineering and clinical supply services. Catalent US: +1 888 SOLUTION www.catalent.com Enclosure systems ClimateZone TM enclosure systems are designed to pro- vide a safe, climatically controlled environment for the handling of sensitive pharmaceutical drug compounds. The ClimateZone air treatment unit provides users with a variety of selectable temperature and humidity profiles, which are automatically maintained. e safe working environment for active drug handling is suit- able for inhalation drug handling. Features include a closed-loop HEPA filtered system, controlled tempera- ture and humidity, mobile self-contained system, no facilities extract required and easy access for mainte- nance and setup. Containment Technology Services UK: +44 2392 695521 www.containment-technology.co.uk Product development and compliant manufacture Hovione offers development and compliant manufac- ture of innovative new drugs and niche generic active pharmaceutical ingredient (API) products. Hovione also supports highly potent compounds and offers pro- prietary product development and licensing opportuni- ties for drug products. e company undertakes formu- lation development and clinical supply of final dosage forms to Phase II. With strong expertise in pulmonary delivery, Hovione also offers APIs for inhala tion, DPI devices and particle engineer ing services. Hovione Portugal: +351 21 982 9000 www.hovione.com